FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Olympus Pays $85 Million for Failing to File Device Reports

[ Price : $8.95]

Olympus Medical Systems and a former senior executive plead guilty to failing to file required adverse event reports involving its...

Indias Skylark CMC Refuses FDA Inspection

[ Price : $8.95]

FDA warns Indias Skylark CMC over its refusal to permit agency inspectors to enter manufacturing areas and refusal to provide requ...

FDA Meeting on Outsourcing Facilities Office Stock

[ Price : $8.95]

Federal Register notice: FDA announces a 5/21 public meeting entitled FDAs Proposed Current Good Manufacturing Practice Policies f...

Revised GMP Guide for Outsourcing Facilities

[ Price : $8.95]

Federal Register notice: FDA makes available a revised draft guidance entitled Current Good Manufacturing Practice Guidance for H...

4 New Biosimilar Guidances

[ Price : $8.95]

FDA commissioner Scott Gottlieb outlines provisions in four guidances to help advance the agencys Biosimilars Action Plan.

HHS Sued Over Trial Reporting Rule

[ Price : $8.95]

Former FDAer Peter Lurie and journalism professor Charles Seife sue HHS, FDA, and NIH to overturn a final rule allowing some drug ...

Biomarker Qualification Draft Guidance

[ Price : $8.95]

FDA issues a draft guidance on the evidentiary framework it recommends for biomarker qualification under the 21st Century Cures Ac...

Amino Acid Polymer Product Assessment

[ Price : $8.95]

CDER issues a MAPP on procedures for integrated quality assessment of products containing drug substances composed of amino acid p...

Latest FDA Warning Letters

[ Price : $8.95]

FDA releases its latest batch of Warning Letters that include Skylark CMC and Zhejiang Huahai Pharmaceutical.

Dishman Carbogen FDA-483

[ Price : $8.95]

FDA released an FDA-483 with two observations issued to Dishman Carbogen Amcis in Gujarat, India.